ClearEdge3D has announced the availability of EdgeWise Plant, an as-built modeling platform that reduces potential errors associated with manual modeling techniques. The platform serves as an ...
Edgewise Therapeutics , Inc. (NASDAQ:EWTX), with a market capitalization of $2.67 billion, is a biopharmaceutical company focused on developing innovative therapies for severe, rare muscle disorders.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Edgewise Therapeutics (EWTX – Research Report) and Cross Country Healthcare (CCRN – Research Report).
- Presenting at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. PT (4:30 p.m. ET) - “We were pleased with our progress in 2024 as we advanced our drug ...
- Presenting at the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 8:15 am PT (11:15 am ET) - BOULDER, Colo., Jan. 13, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc., ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...
- Presenting at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 8:15 am PT (11:15 am ET) - "2025 marked a year of disciplined execution and substantial advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results